Researchers are conducting the first clinical trial to examine how selective estrogen receptor modulators’ (SERMs) may help both men and women suffering from schizophrenia.
A recent review has found that almost three in 10 adult hospital patients in high-income countries may have the deficiency.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
Methotrexate is commonly used in Australia and around the world for conditions such as rheumatoid arthritis.
What began as a heart research project looking at ways to understand a potentially fatal but preventable disease has evolved from the biomedical into one more in keeping with an Indigenous perspective.
A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
Can genetically-modified cell therapies correct the immune system’s mistaken attack of healthy cells and tissues?
As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now, with treatments are on the horizon, the new race is to ready the health system.
The virus is related to Hendra and Nipah viruses. But we don’t know whether it spreads from human to human.
Why aren’t we creating more art about this metamorphic life stage experienced by half the population?
New research shows the ongoing effects from critical illness with COVID-19 can be long and serious.
A lot has changed in COVID treatment since the pandemic began. Here are the treatments you can expect — from being diagnosed, to going to hospital, and for those who need to be cared for in ICU.
For only the second time in 60 years, a drug has been approved for the treatment of lupus, a debilitating form of rheumatic disease.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
It’s been described as feeling like your brain is on fire, and can be characterised by delusions and hallucinations. But those with autoimmune encephalitis aren’t crazy, they’re ill.
They're low-cost medicines that can be easily accessed, and are being used to treat seriously ill COVID-19 patients.
Most people diagnosed with COVID-19 can manage their illness at home, but some patients deteriorate after about five days. Fortunately, Australian doctors have up-to-the-minute treatment guidelines.
Thomas Ko is spearheading innovative technology that takes injectable medicines and transforms them into pills.
Combating a virus that can cause disease and life-threatening transplant complications is the focus of Eureka Prize-winning research.
A pregnancy hormone may provide the first effective treatment in combating the silicosis epidemic.
There are no approved treatments or cures, and more research is urgently needed for the debilitating illness.
Vaccination may one day allow coeliac disease sufferers to have their cake and eat it, too – but many questions remain unanswered.
Think you're tough? In the survival stakes, we humans have nothing over our bacterial companions.
Dummy text